Our Production Capacity
CinnaGen has advanced production infrastructure for manufacturing biopharmaceuticals, including recombinant proteins and monoclonal antibodies.
Our Production Capacity
CinnaGen has advanced production infrastructure for manufacturing biopharmaceuticals, including recombinant proteins and monoclonal antibodies. These facilities cover everything from cell culture to purification and final product preparation.
Key Production Capacities:
- Annual production of recombinant proteins:Up to 100,000 grams per year
- Annual production of monoclonal antibodies:Up to 500 kilograms per year
- Bioreactor capacity:18,000 liters
- Fermenter capacity:2,000 liters
These capacities enable sustainable, scalable, and expandable production for complex biopharmaceuticals.
Virtual Production Tour
View Virtual TourOur Production Spaces
